NOX4 and cystic fibrosis: These data provide additional evidence for the role of β-arrestins in regulating CF biology and for the potential novel therapeutic role of inhibiting Nox4-mediated mitochondrial ROS production through β-arrestins in the prevention of maladaptive cardiac remodeling and the development of HF.